2nd LNP Immunogenicity and Toxicity Summit

Confidently Predict LNP Immunogenicity and Safety Profiles to Maximize Therapeutic Windows and Optimize Translatability Into the Clinic

Time: 9:00 AM – 5:00 PM

Venue Details: Boston Park Plaza, 50 Park Plaza, Boston, Massachusetts, 02116, United States

Prices:
Full Access Pass (Conference + Workshop Day) – Drug Developer Pricing: USD 5046.00,
Conference Only – Drug Developer Pricing: USD 3099.00,
Full Access Pass (Conference + Workshop Day) – Academic Pricing: USD 4246.00,
Conference Only – Academic Pricing: USD 2599.00,
Full Access Pass (Conference + Workshop Day) – Service Provider Pricing: USD 6046.00,
Conference Only – Service Provider Pricing: USD 3799.00

Speakers: Amy Rosenberg, Senior Director of Immunology and Protein Therapeutics, Epivax, Daryl Drummond, Chief Scientific Officer, Akagera Medicines, Esmaiel Jabbari, Professor of Chemical and Biomedical Engineering, University of South Carolina, Hicham Alaoui, Chief Scientific Officer General, Glycomine, Jake Brenner, Associate Director and Assistant Professor – Medicine, University of Pennsylvania, Jan Diekmann, Senior Director Non-clinical Safety, BioNTech, Jian Lu Chief, Scientist Director of Toxicology, Nitto BioPharma, and more